In the rat model of DZN-induced hepatotoxicity, crocin (12.5 and 25mg/kg/day, IP) inhibited hyperlipidemia through the declined inhibition of ERK performance, and increased LDL receptor expression (157). The gene discussed is MAPK1; the disease is hyperlipidemia.